IMPORTANT: As of October 13, 2026, our Terms and Conditions have updated. This includes updates to our dispute resolution which requires binding arbitration and includes a waiver to jury trials and class actions (you may opt out as provided in our terms).

Click Here to read Terms & Conditions

Our Pipeline

Advancing a Pipeline in Autoimmune Diseases Led by SAB-142